Seeking Alpha

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven ...

ZUG, Switzerland--(BUSINESS WIRE)-- Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane ® Lyft™ or Contour™ in combination with Sculptra ® ...
Joplin Globe

Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for ...
Business Wire

AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum

ZUG, Switzerland--(BUSINESS WIRE)--Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7 ...
Reuters

Galderma SA

L'Oreal to increase stake in skin care firm Galderma to 20% L'Oreal will double its stake in Swiss skin care firm Galderma to 20%, it said on Monday, potentially earning the French company a bigger ...